Key words: acetylcholine --a-bungarotoxin --autoradiography --carotid body --dopamine release --nicotinic receptors Acetylcholine and nicotinic agents excite cat carotid body chemoreceptors and modify their response to natural stimuli. The present experiments utilized [125I]a-bungarotoxin ([125I]a-BGT) to localize within the chemosensory tissue the possible sites of action of exogenous and endogenous nicotinic cholinergic substances. In vitro equilibrium binding studies of intact carotid bodies determined a K d of 5.57 nM and a Bma x of 9.21 pmol/g of tissue. Chronic section (12-15 days) of the carotid sinus nerve (CSN) did not change the amount of displaceable toxin binding. In contrast, the specific binding was reduced by 46% following removal of the superior cervical ganglion. Light microscope autoradiography of normal, CSN-denervated and sympathectomized carotid bodies revealed displaceable binding sites concentrated in lobules of type I and type II cells. Treatment of carotid bodies with 50 nM a-BGT in vitro reduced by 50% the release of [3H]dopamine (synthesized from [3H]tyrosine) caused by hypoxia or nicotine, and also significantly reduced the stimulus-. evoked discharges recorded from the CSN. The data suggest (1) an absence of ct-BGT binding sites on the afferent terminals of the CSN and (2) that nicotinic receptors located within parenchymal cell lobules may modulate the release of catecholamines from these cells.
INTRODUCTION
The carotid body is an arterial chemosensory organ whose parenchyma consists of two distinct cell types in close association with a dense capillary network. Type I (glomus) cells possess abundant dense and clear cored synaptic vesicles, mitochondria and a highly conspicuous rough endoplasmic reticulum.
Specialized terminals formed by afferent fibers from the carotid sinus nerve (CSN) synaptically appose the type I cells while slender cytoplasmic processes of type II cells, whose cytology resembles Schwann cells, envelop the afferent terminal-glomus cell complex.
In 1936, Heymans et al. 34 were the first to observe that small intracarotid doses of acetylcholine (ACh) stimulated respiration in a manner similar to natural stimulation of the carotid body. In the ensuing decades, numerous studies investigated the role of ACh in chemosensation and demonstrated that small quantities of cholinergic agonists and antagonists profoundly altered chemoreceptor discharge 20. Neurochemical investigations indicated that the metabolic machinery necessary for ACh synthesis, storage and inactivation appear to be associated with type I cells in the carotid body 2, 3, 23, 24, 31, 35, 36 and that afferent fibers of the CSN are nearly devoid of cholinergic activity23, 28. In addition, it has been demonstrated that an ACh-like substance is released upon stimulation of the organ in vitrol7, Is.
While these data support the notion that ACh may play a role in carotid body chemoreception, the precise actions of this substance in the sensory process has been elusive, particularly with respect to its putative action as a mediator or transmitter of chemosensory information from the type I cells to the afferent fibers of the CSN. Disagreement about the function of ACh stems from the observations that (1) anticho-
